Your browser doesn't support javascript.
loading
Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting.
Buettner, Ralf; Morales, Corey; Caserta, Enrico; Troadec, Estelle; Gunes, Emine G; Viola, Domenico; Khalife, Jihane; Li, Hongzhi; Keats, Jonathan J; Christofferson, Austin; Wu, Xiwei; Synold, Timothy W; Palmer, Joycelynne; Sanchez, James F; Pozhitkov, Alexander; Vaidehi, Nagarajan; Marcucci, Guido; Krishnan, Amrita; Rosenzweig, Michael A; Pichiorri, Flavia; Rosen, Steven T.
Afiliação
  • Buettner R; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Morales C; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Caserta E; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Troadec E; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Gunes EG; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Viola D; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Khalife J; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Li H; Department of Computational and Quantitative Medicine, City of Hope, Duarte, CA.
  • Keats JJ; Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, AZ; and.
  • Christofferson A; Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, AZ; and.
  • Wu X; Integrative Genomics Core, Department of Molecular Medicine, Beckman Research Institute.
  • Synold TW; Department of Cancer Biology, Beckman Research Institute, and.
  • Palmer J; Department of Computational and Quantitative Medicine, City of Hope, Duarte, CA.
  • Sanchez JF; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Pozhitkov A; Department of Computational and Quantitative Medicine, City of Hope, Duarte, CA.
  • Vaidehi N; Department of Computational and Quantitative Medicine, City of Hope, Duarte, CA.
  • Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, Duarte, CA.
  • Krishnan A; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Rosenzweig MA; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Pichiorri F; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
  • Rosen ST; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, Hematologic Malignancies and Stem Cell Transplantation Institute, and.
Blood Adv ; 3(7): 1027-1032, 2019 04 09.
Article em En | MEDLINE | ID: mdl-30940637
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-myc / Proteínas Proto-Oncogênicas c-pim-1 / Leflunomida / Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-myc / Proteínas Proto-Oncogênicas c-pim-1 / Leflunomida / Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article